BRISBANE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (NASDAQ:ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, today announced that Douglas Love, Esq., president & chief executive officer, will participate in fireside chats during the following September investor conferences: Wells Fargo Healthcare Conference on Wednesday, September 3, 2025, at 3:00 p.m. ET in Boston, MA; and,Cantor Global Healthcare Conference on Thursday, September 4, 2025, at 8:00 a.m. ET in New York, NY. Live webcasts of the presentations ca